|
Market Closed -
Euronext Paris
16:55:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 36.35 EUR | +0.28% |
|
+0.55% | -15.56% |
| 09-09 | NEURONES Reaffirms Earnings Guidance for the Full Year of 2026 | CI |
| 09-09 | Neurones S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 45 | +23.8% | 1 | ||||
| 245.35 | +0.85% | 23 | ||||||
| 418.29 | +27.14% | 48 | ||||||
| 183.59 | -0.17% | 25 | ||||||
| 2,470.17 | +12.24% | 41 | ||||||
| 33.98 | +37.28% | 17 | ||||||
| 1,203.86 | +16.01% | 42 | ||||||
| 4,801.54 | +28.08% | 13 | ||||||
| 6,270.83 | +38.25% | 12 | ||||||
| 1,263.59 | +4.77% | 39 | ||||||
| 182.37 | +9.53% | 43 | ||||||
| 68.45 | +26.34% | 22 | ||||||
| 29.15 | +30.76% | 15 | ||||||
| 64.18 | +6.97% | 25 | ||||||
| 321.4 | +9.8% | 5 | ||||||
| 829,545.45 | +41.8% | 11 | ||||||
| 436.1 | +5.92% | 10 | ||||||
| 140.51 | +36.55% | 17 | ||||||
| 5,913.57 | +20.66% | 14 | ||||||
| Average | 44,928.28 | +19.82% | 22 | ||||||
| Weighted average by Cap. | 21,164.21 | +14.86% | 27 |
- Stock Market
- Stocks
- NRO Stock
- Sector NEURONES
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
